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Clinical decision analysis is a knowledge and labor intensive task. This thesis presents 
a new approach to support automated construction of clinical decision models from a 
knowledge base. The methodology aims to facilitate application of the decision 
analysis paradigm in clinical domains. We make use of the knowledge-based Clinical 
Practice Guideline (CPG) model in Guideline Interchange Format (GLIF) as the input 
knowledge model. Together with the medical ontologies, which provide structured 
data models and controlled vocabularies for referencing patient conditions and 
therapies that are relevant to managing disease, it builds up the knowledge base for 
clinical decision making.   
 
We develop an algorithm to automatically build a rough decision model (RDM) from 
the knowledge base described above. The RDM is a decision model that is not 
complete in the structure, or parameters, or both. However, it gives a neat view of the 
decision problem with the information extracted from the knowledge base. Rule-based 
references are widely used in many guideline-based decision models. We incorporate 
expected values computed from a decision-theoretic model to the hierarchical 
representation framework. In addition, it greatly reduces the efforts needed for 
constructing a decision model manually. With the rough model, the decision maker 
could construct the complete decision model by modifying the RDM and filling in 
additional information like probabilities and utilities.  
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1.1.1 Decision Analysis 
 
1.1.1.1 Decision Problems 
 
Decisions are any action that a problem solver may take in structuring problems in 
reasoning in allocating computational resources in displaying information or in 
controlling some physical activity [Horvitz et. al., 1988]. Many real-world decisions 
are hard to make due to the following reasons [Clemen 1996]: 
• complexity -- many possibilities and alternatives 
• uncertainty -- the future is not known for sure and available information is 
vague or based on estimation. 
• multiple conflicting objectives -- many objectives are in conflict with each 
other and values of many affected parties may be different or conflicting. 
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• Diversity of opinions and perspectives -- different affect parties have different 
perspective of the problems and different people may have different risk 
attitude. 
 
1.1.1.2 Decision Analysis Process 
 
Probability provides a language for making statements about uncertainty and thus 
makes explicit the notion of partial belief and incomplete information. Decision theory 
extends probability theory, to allow us to make statements about what alternative 
actions are and how alternative outcomes the results of actions are valued relative to 
one another. Probability theory and the more encompassing decision theory provide 
principles for rational inference and decision making under uncertainty. 
 
Decision analysis is an engineering discipline that addresses the pragmatics of 
applying decision theory to real-world problems. The Decision Analysis Process 
[Holtzman 1989], which consists 4 iterative phases: decision problem formulation, 















Figure 1.1 Decision Analysis Cycle 
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In the first phase -- formulation, the decision maker conceptualize and structure the 
decision problem into a model which contains the alternatives (list of possible actions 
that may be taken to address the problem), information (possible events and factors 
that are relevant to the problem), and preference or value (desirability of different 
consequences).  
 
The second phase, evaluation, is to find out what is the recommended alternative. The 
procedure could be separated into deterministic analysis and probabilistic analysis. In 
the deterministic analysis, we need to construct the value model and identify the 
uncertainty factors that have the largest impact on the consequences. In the 
probabilistic analysis, probability distributions of the events and risk profile of each 
alternative are assessed, and then the best alternative is determined.       
 
 
In the appraisal phase, more sensitivity analysis is performed to test the robustness of 
the recommended alternative.  
 
The revision phase is necessary if the above three phases do not come up with a 
clarified action or the recommended alternative is not suitable for the problem. Then 
we need to restart from the formulation phase, and perform a new iteration of the 
decision analysis until we find the best alternative to deal with the problem.  
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1.1.2 Knowledge-Based Clinical Decision Making  
 
In recent years, clinical decision analysis plays an increasingly important role in the 
healthcare community. Decision models (DMs) enable clinicians and analysts to assess 
the expected utility of alternative actions in situations that involve uncertainty, 
complexity, and dynamic change; to communicate explicitly assumptions about the 
structure of a problem; to determine the importance of uncertainty with sensitivity 
analyses; to determine the benefit of gathering further information through value-of-
information calculation; and to make probabilistic inference conditioned on evidence 
[Owens and Nease 1993, Owens and Sox 1990].  
 
Medical decision making often incorporates knowledge of the medical domain, results 
of published research, physicians’ experiences and heuristics, patient preferences and 
quality of life issues. However, clinical decision analysis is a knowledge intensive task. 
Most of the time, the clinical model construction process is burdensome and time-
consuming. Consequently, to facilitate the automation of model construction, efforts in 
developing knowledge-based model construction (KBMC) systems have emerged in 
recent years [Wellman et al. 1992, Breese et al. 1994]. It is hoped that by capturing the 
relevant knowledge in the knowledge bases, a well trained analyst or a domain expert 
would seldom be needed in the decision modeling process. Consequently, the cost of 
applying the decision-analytic methods in decision making could be greatly reduced 
[Wellman et al., 1992] [Leong, 1998].  
 
In the medical domain, the knowledge bases usually contains ontologies, which are 
models describing concepts and the relationships among them, combining an 
Chapter 1 Introduction 
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abstraction hierarchy of concepts with a semantic network of relationships.  
Information models (such as the Health Level 7 Reference Information Model (HL7 
RIM)), and standardized vocabularies (such as Unified Medical Language System 
(UMLS)) can be part of an ontology.  Ontology provides a core component in a 
knowledge-based system. 
 
1.1.3 Clinical Practice Guidelines 
 
The Clinical Practice Guidelines (CPGs) are defined by the Institute of Medicine (IOM) 
as “statements to assist practitioner and patient decisions about appropriate health care 
for specific circumstances” [IOM 1992]. CPGs provide a systematic means to review 
patient management and a formal description of appropriate levels of care, to reduce 
inappropriate variations in practice, to improve health care quality, and to help control 
costs [IOM 1992]. CPGs are being used for many different applications including 
screening, risk assessment, diagnosis, treatment, and monitoring of patients for a 
variety of medical problems.  
 
CPGs can be represented in several different formats, including text, protocol charts or 
lists, flowcharts, or any combination thereof, and computer-based formats, such as The 
Arden Syntax, [Hripcsak et al., 1994], and GuideLine Interchange Format (GLIF)  
[Ohno-Machado et al., 1998] [IOM, 1992]. 
 
Some CPGs are developed based on expert opinion, local practice, or consensus. Some 
CPGs -- Evidence-based CPGs -- are created using well assessed, formalized medicine 
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knowledge and clinical literature [Evidence-Based Medicine Working Group 1992]. 
With the knowledge acquisition and editing tools, computerized evidence-based CPGs 
could be formulated as clinical knowledge models. And along with controlled 
vocabulary for referencing patient conditions and therapies relevant to managing 
disease, knowledge-based CPG models are desirable knowledge base for clinical 




GuideLine Interchange Format (GLIF) is a format for encoding and sharing computer-
interpretable clinical guidelines developed by the InterMed Collaboratory, a joint 
project of medical informatics groups at Harvard, Stanford, and Columbia universities. 
The latest version is GLIF3.5. 
 
GLIF will allow sharing of computer-interpretable clinical guidelines across different 
medical institutions and system platforms, facilitating the contextual adaptation of a 
guideline to the local setting and integrating them with the electronic medical record 
systems. GLIF has a formal representation. It defines an ontology for representing 
guidelines, as well as a medical ontology for representing medical data and concepts. 
The medical ontology is designed to facilitate the mappings from the GLIF 
representation to different electronic patient record systems.  
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1.1.5 Knowledge Acquisition and Protégé – 2000 
 
Electronic knowledge representation is becoming more and more pervasive both in the 
form of formal ontologies and less formal reference vocabularies. In addition, internet 
has opened up an unprecedented opportunity to build up powerful large-scale medical 
knowledge base. In these systems, a cost-effective medical knowledge acquisition and 
management scheme is highly desirable to handle the large quantities of, often 
conflicting, medical information collected from medical experts in different medical 
domains and from different regions. 
 
Protégé is an ontology-development and knowledge-acquisition environment 
developed by the Stanford Medical Informatics group (http://protege.stanford.edu). 
The current version, Protégé-2000, can run on a variety of platforms, support 
customized user-interface extensions, incorporates the Open Knowledge Base 
Connectivity (OKBC) knowledge model, interacts with standard storage formats such 
as relational databases, Extensible Markup Language (XML), and Resource 
Description Framework (RDF), and has been used by hundreds of individuals and 








Chapter 1 Introduction 
 8
1.2 Motivations & Objectives 
 
Clinical decision analysis is a knowledge and labor intensive task. With the knowledge 
acquisition and editing tools, such as Protégé-2000, computerized evidence-based 
CPGs could be formulated as clinical knowledge models. Along with medical 
ontologies, which provide a data model and a controlled vocabulary for referencing 
patient conditions and therapies relevant to managing disease, CPG models are 
desirable knowledge base for clinical decision making. We develop an algorithm to 
automatically generate a rough decision model, from the knowledge-based CPG 
model. Thus, the efforts needed for constructing a clinical decision model manually 
would be greatly reduced and the decision maker could construct the complete 
decision model by modifying the rough decision model and filling in additional 
information. The use of controlled vocabulary and structured data models to develop 
the clinical decision model will also ease the reuse and exchange of decision models 
among different groups of users.    
 
In addition, many guideline-based decision models use rule-based criteria (e.g., if a 
patient is febrile and neutropenic, then institute broad-spectrum antibiotics) as a way of 
setting qualitative preferences. However, it does not incorporate uncertainty and the 
value of outcomes into clinical decision making. Formalizing the decision-making 
process forces clinicians to confront the assumptions and uncertainties underlying 
decisions. We envision incorporating another method: use of expected values 
computed from a decision-theoretic model. We will use influence diagram (which will 
be introduced in detail in Chapter 2) as the decision model. The proposed system 
architecture are shown in Figure 1.2. 





















Figure 1.2 The Proposed System Architecture 
 
 
1.3 Overview of the Thesis 
 
This introductory chapter has briefly described the research background, motivations 
and objectives, the proposed approach and its possible application domains. The 
remainder of the thesis is structured as follows: Chapter 2 details the clinical decision 
model construction, representation and ontological features of the decision model. The 
knowledge-based CPG system is discussed in Chapter 3. We will introduce the Protégé 
knowledge model, medical ontology, and guideline model in GLIF. Chapter 4 gives a 
detailed description of our new methodology and system architecture, including the 
related works, assumptions, and the mapping from the knowledge-based GLIF 
guideline model to rough decision model. Chapter 5 presents a case study on applying 
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the proposed framework to the chronic cough management guideline model. Finally, 
Chapter 6 summarizes this work and discusses the contributions and limitations of our 
methodology, and future work.  
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Chapter 2  
Clinical Decision Model Construction 
 
2.1 Introduction to Clinical Decision Model 
 
A DM, which is an abstract representation of a decision problem, takes into account 
the uncertain, dynamic, and complex consequences of a decision, and assigns values to 
those consequences [Owens and Nease 1993, Owens and Sox 1990]. In the clinical 
domain, a DM is a simplification of the real clinical situation; therefore, the DM 
reflects the decision maker’s conception of how a treatment or screening intervention 
is used and the way in which that intervention affects the natural course of the disease, 
and the health status of the target patient population [Gold et al., 1996].  
 
Guided by the characterized background information, a decision problem is formulated 
within the clinical context by identifying 1) the most relevant diseases/hypotheses 
involved, 2) the most relevant actions available, 3) the relative significance, possible 
outcomes, and complications of the concepts derived from 1) and 2), and their effects 
on each other, and 4) the evaluation criteria concerned [Owens 1997].  
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2.2 Decision Model Representations  
 
In this section, we introduce some background about DM representation. Uncertainty 
is an inherent issue in nearly all medical problems. The prevailing method to manage 
various forms of uncertainty today is formalized within a probabilistic framework. 
Decision Trees (DTs), Influence Diagrams (IDs), Bayesian Networks (BNs), and 
Qualitative Probabilistic Networks (QPN) are the most common graphical 
representations. Among them, BN and QPNs are variants of the IDs. So we will 
introduce IDs in more detail.  
 
2.2.1 Decision Trees 
 
Traditionally decision analysis is carried out by using decision trees [Raiffa 1968]. 
Decision trees represent the probabilistic relationships and influences among variables 
in a DM according to the variables’ observation ordering. An example is shown in 
Figure 2.1. It displays the decision tree representation for a chronic cough treatment 
decision problem [Lin et al, 2001], the different treatment alternatives and the 
corresponding treatment outcomes, and the utilities. Squares represent decisions to be 
made, while circles represent chance events. The branches emanating from a square 
correspond to the choices available to the decision maker, and the branches from a 
circle represent the possible outcomes of a chance event. The third decision element, 
the consequence, is specified at the ends of the branches. "Treat all 3" means treat all 
the three causes for chronic cough -- Post Nasal Drip Syndrome (PNDS), asthma, 
Gastroesophageal Reflux Disease (GERD) -- all together. The option do no treat all 3 
are not shown in the decision tree.  



















































Figure 2.1 Decision Tree representation of the chronic cough treatment problem 
 
2.2.2 Influence Diagrams 
 
One big problem with the decision tree representation is that it grows exponentially in 
size as the number of relevant variables increases. A more compact framework called 
influence diagrams was introduced by Howard and Matheson in 1984. IDs are also 
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more intuitive and reveal more problem structures. They have enabled researchers to 




An influence diagram is a directed acyclic graph with no cycles. There are four types 
of nodes. A decision node (drawn as a square), provides the decision alternatives under 
consideration. A chance node (drawn as a circle), represents a variable whose value is 
a probabilistic function. The value node (drawn as a diamond) represents the outcome 
of interest. Generally, each influence diagram has only one value node. Deterministic 
node (drawn as double oval) is a special type of chance nodes. It represents a variable 
whose outcome is deterministic, once the outcome on one or more of other nodes are 




The directed arcs in an influence diagram represent relations between the nodes 
connected.  
 






Figure 2.2 Relevance arc 
The outcome of event A is relevant for assessing the chances associated with event B. 
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Figure 2.3 Influence arc 
 
Decision D is relevant for assessing the chances associated with event B.  
 





Figure 2.4 Information arc 








Figure 2.5 Chronological arc 
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• Value arc 
 
Figure 2.6 Value arc 
Variable A has direct impact on Value V.  
Decision D has direct impact on Value V. 
 
Figure 2.7 shows the influence diagram for the same problem described in Figure 2.1. 
We could see it is a compact graphical representation of the probabilistic relationships 
















A V V D 




Most IDs could be rolled back to decision trees. Rollback is conducted from right to 
left, taking expected values at every uncertainty node and selecting the best action 
alternative at every decision node. The ultimate purpose of building an influence 
diagram for a decision problem is to compute the optimal course of actions to be taken. 
Such a process of finding the optimal solution is called evaluating the diagram. There 
are two ways to solve it: 1) Convert the ID into an equivalent decision tree and use the 
tree roll back technique to find the solution. 2) Manipulate the ID directly by graphical 
operations on the nodes and arcs.  
 
Shachter (1986) developed a method for evaluating IDs directly by arc reversal and 
node reduction from the ID through a series of value-reserving transformations. Each 
transformation leaves the expected utility unaltered, and during the operation of the 
algorithm the optimal decisions are computed. Shenoy (1992) described a more 
efficient algorithm that works on a structure similar to the ID, called a valuation based 
system. Here the nodes are removed from the network by fusing the valuations bearing 
on the nodes that are to be removed. Jensen et al. (1994) provided an algorithm that 
works on a higher-level graphical structure, the strong junction tree. They showed how 
to compile the ID into a strong junction tree, and their algorithm can be regarded as 
proceeding by the propagation of flows from the leaves to the strong root of the strong 
junction tree. During this ‘collection-phase’, the optimal strategy is computed. Dechter 
(1996) proposed a unifying framework for probabilistic inference in Bayesian 
networks and ID, called bucket elimination. It emphasizes the principle common to 
many of the algorithms appearing in the literature and clarifies their relationship to 
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nonserial dynamic programming algorithms. A general way of combining conditioning 
and elimination was also presented in his framework.   
 
Besides the direct evaluation methods described above, there are some studies [Cooper  
1988; Shacter and Peot 1994; Zhang 1998; Xiang et al, 2001] on reducing ID 
evaluation into Bayesian network (BN) inference problems that are easy to solve.  
 
2.2.3 Bayesian Networks 
 
IDs without decision and value nodes are called Bayesian networks (also known as 
Bayesian belief networks, causal networks, or probabilistic networks) [Pearl 1988]. 
They are widely used by Artificial Intelligence (AI) researchers as a knowledge 
representation framework for reasoning under uncertainty. BNs are also directed 
acyclic graphs with nodes representing random variables and edges representing 
conditional dependencies. The random variable could be either discrete or continuous. 
Figure 2.8 represents the well-known Asia problem which models a diagnosis problem 
in clinical domain.   
 
There is a rich collection of exact and approximate algorithms for inference in BNs 
[Kim and Pearl 1983, Lauritzen and Spiegelhalter 1988, Jensen et al 1990, Shafer and 
Shenoy 1990].   
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Figure 2.8 Bayesian Network representation example 
 
2.3 Ontological Features of Clinical DM 
 
We should not only concentrate on the structural components of the model such as 
nodes, conditional probabilities, and influences, but also focus on the ontological 
features of the decision problem such as contexts, classes of observed events, classes 
of available actions, classes of possible outcomes, temporal precedence, and 
probabilistic and contextual dependencies [Leong 1990].  
 
To gain insights into the nature of a clinical decision, we introduce some relevant 
clinical concepts through a cancer treatment example. Figure 2.10 shows the nodes and 
their relationship of a typical disease treatment problem.  
 
Disease & background (Chance node) Cancer affects the entire world’s population, 
with about a threefold difference between areas with the highest and lowest age-
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adjusted rates. For certain cancers, the geographic patterns are very obvious and 
noteworthy. In addition, some risk factors also have been identified for specific 
cancers, such as tobacco, alcohol, occupational hazards, environmental pollution, 
medicinal agents, radiation, diet and nutrition, infectious agents and genetic 
susceptibility. The geographic patterns and risk factors could be a set of sub-classes 
that represent the variables that give the background information of the disease in the 
class Disease & background. The possible outcomes of a specific chance node could 
be absence or presence of the factor. In addition, age, gender, tobacco, alcohol, diet 
and nutrition are attributes of the patient class. The graphical depiction of 






Age  gender  tobacco?  
Alcohol?  












Figure 2.9 Graphical depiction of interconnection model for disease & 
background 
 
Signs and Symptoms (Chance node) These are conditions observed by the physician or 
reported by the patient. In the graphic representation, they usually comprise a set of 
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classes to describe the characteristics of the disease, for example (cancer), usual 
behavior, rate of growth, mode of spread, local or systemic. 
 
Test (Decision node) A diagnostic test is an action in which the existence status of a 
state or a process is revealed by observing the test results. The alternatives could be 
physical examination, laboratory tests, imaging, and biopsy. We usually associate the 
following properties with a test: sensitivity, which is a measure of how accurate the test 
is to confirm an infection or a disease; specificity, which is a measure of how accurate 
the test is to rule out a disease; complications; mortality rate, which is a measure of 
how often death results from performing the test; and monetary costs.  
 
Test Result (Chance node) It is the laboratory findings of a specific test. The outcome 
could be only one node to state the absence or presence of the finding, positive or 
negative of the test. It could also be composed of a set of nodes. For example, the 
observation of the Mammogram in breast cancer diagnosis, is a set of nodes that 
include the mass findings (margins, shape, size, density, etc), associated findings (skin 
lesion, skin thickening, skin retraction, etc), and special cases (tubular density, lymph 
node, asymmetric breast tissue, etc).  
 
Treatment (Decision node) A treatment for disease alleviates the severity of the disease.  
It is a set of available alternatives for treatment. The common alternatives could be 
chemotherapy, radiotherapy, biologic therapy, and surgery. 
 
Treatment outcome (Chance node) It represents the possible outcomes of the treatment, 
like cured, improved, not-improved, worsened, death. In the oncology domain, the 
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possible outcomes of the treatment would include well, recurrence, metastases, 
recurrence and metastases. 
 
Treatment complication (Chance node) It represents the possible complications 
resulting from the treatment.  
 
Follow-up (Decision node) The follow-up process is the maintenance of contact with 
or reexamination of the patient, especially the following-treatment. 
 
Follow-up outcome (Chance node) It represents the possible outcomes of the follow-up 
process. It could also be well, recurrent, metastatic, recurrent and metastatic, etc. 
 
Follow-up complication (Chance node) It represents the possible complications 
resulting from the follow-up.  
 
Cost (Deterministic node) It presents the amount of the monetary cost and is 
deterministic once the outcome of all the other nodes linked to it are known. 
 
Quality adjusted life expectancy (QALE) (Deterministic node) It is a measure of the 
time remaining in a patient’s life, taking into account the inconveniences caused by the 
illness (morbidity). If the outcomes of all the other nodes linked to it are known, the 
outcome of QALE is deterministic.  
 
Value (Value node) It represents the overall preference conditioned on the factors 
affect the decision maker.  






















      Cost 
 
 
Figure 2.10 Representation of a typical clinical DM 
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Chapter 3  
The Knowledge-based CPG system 
 
 
In this chapter, we will first introduce the Protégé-2000 knowledge acquisition and 
editing tools. Then we will discuss the building blocks of the knowledge base, medical 
ontology, which is represented in 3 levels of abstraction in GLIF. The details of the 
GLIF guideline model are also illustrated.    
 
3.1 Knowledge Modeling Environment – Protégé-2000 
 
3.1.1 Introduction to Protégé  
 
Several guideline modeling groups (e.g., EON [Musen et al., 2000], PRODIGY 
[Johnson et al., 2000], GLIF [Peleg et al., 2000]) and developers of decision support 
systems have chosen Protégé as their knowledge acquisition tool. Its automatic user-
interface generation facility shows the new guideline model to the domain-specialists 
immediately.  
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Protege-2000 is an ontology-development and knowledge-acquisition environment 
developed by the Stanford Medical Informatics group.  The current version, Protégé-
2000, can be run on a variety of platforms, supports customized user-interface 
extensions, incorporates the Open Knowledge Base Connectivity (OKBC) knowledge 
model, interacts with standard storage formats such as relational databases, XML, and 
RDF, and has been used by hundreds of individuals and research groups. Protégé is 
open source and currently has more than 7,500 registered users [Gennari et al., 2002]. 
 
Protégé could also store both domain knowledge (controlled-vocabulary concepts) and 
large amounts of data (results from experimental studies), which are two important 
components for medical decision making.  
 
3.1.2 Protégé-2000 knowledge model 
 
Protégé uses a frame-based, hierarchical knowledge-representation system. Protégé 
ontology consists of classes, slots, facets, and axioms. Classes are concepts in the 
domain of discourse, organized in a hierarchy, and each class has at least one parent. 
Classes have slots whose values may or may not be inherited. Slots describe properties 
or attributes of classes. Facets describe properties and the data type of the slot value 
(e.g., string, integer, enumerated symbols, or instance of another class). Axioms 
specify additional constraints. A Protégé-2000 knowledge base includes the ontology 
and individual instances of classes with specific values for slots [Noy et al., 2000]. 
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The medical knowledge base contains the domain knowledge required to formulate the 
decision model.  
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3.2 Medical ontology 
 
3.2.1 Introduction to ontology 
 
An ontology is an explicit specification of the conceptualization of a domain and it 
provides a core component in a knowledge-based system.  Information models (such as 
the HL7 RIM) and standardized vocabularies (such as UMLS) can be part of an 
ontology. 
 
In the clinical research field, ontologies have been used in computerized guideline 
modeling.  This allows the development of applications to provide recommendations 
(e.g. to make indications for the use of surgical procedures), to identify deviations in 
practices, and screening services (e.g. evaluate patient eligibility). 
 
Benefits of using ontologies include: 1) Facilitating sharing between systems and reuse 
of knowledge; 2) Aiding new knowledge acquisition; 3) Improving the verification and 
validation of knowledge-based systems. 
 
3.2.2 Medical Ontology in GLIF 
 
The support of the ontological needs for guideline modeling in GLIF is separated into 
three layers, correlated to levels of abstraction. The first layer, Core GLIF, is part of 
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the GLIF specification language. It defines a standard interface to medical data items 
and concepts, and to the relationships among them.  
 
The second layer, Reference Information Model (RIM), is essential for guideline 
execution and data sharing among different applications and different institutions. It 
defines the basic data model for representing medical information needed in specifying 
protocols and guidelines. It includes high-level classification concepts, such as 
medications and observations about a patient, and attributes, such as units of a 
measurement and dosage for a drug, that medical concepts and medical data may have. 
The default Reference Information Model (RIM) that GLIF3 supports is HL-7’s RIM 
version 1, also known as the Unified Service Action Model (USAM). 
 
GLIF clinical decisions and actions refer to patient data items. Each patient Data_Item 
is defined by a medical concept, taken from some standard controlled vocabulary, and 
by a data model class and source. The data model class and source indicate the 
Reference Information Model (RIM) class and RIM model that is used for defining the 
data item’s data structure.  
 
The third layer, Medical Knowledge Layer is still under development. It will be 
specified in terms of the methods that it should have for interfacing to the following 
medical knowledge sources: 
• Controlled vocabularies, like UMLS, that define medical concepts by giving 
them textual definitions and unique identifiers. 
• Medical knowledge bases that define medical knowledge, such as drug 
hierarchies, and normal ranges for test results. 
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• Clinical repositories (EMRs) 
• Other clinical applications, such as order entry systems, alert/reminder systems. 
 
When all three layers are involved, they work closely together: Core GLIF relies on the 
RIM to supply the attributes of the medical concepts and to represent data values. Core 
GLIF relies on the Medical Knowledge Layer for accessing specific medical concepts. 
 
In the three-layered medical ontology, users have the freedom to choose a particular 
RIM and a particular medical knowledge layer that fits their needs. Using a single RIM 
and a single controlled vocabulary to encode one guideline will ease the process of 
sharing the guideline, since mapping terms that belong to different RIMs and 















































































































































































































































































   















   

























   
   
   













































































   
   
   

































































































































































































   
   
   










































   
   



































   













































































































































































   
   
   
   













































































































































Figure 3.2 Example of the step hierarchy and medical ontology support 
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3.3 Clinical Practice Guideline Model in GLIF 
 
GuideLine Interchange Format (GLIF) is a formal representation model for guidelines, 
created by the InterMed Collaboratory as a proposed basis for a shared representation 
for CPGs. InterMed is a joint project of medical informatics groups at Harvard, 
Columbia, and Stanford Universities, along with other participants, which has been 
working on GLIF since 1996. A specification for GLIF version 2.0 (GLIF2) was 
published in 1998 [Ohno-Machado et al., 1998]. Prototype tools for authoring, 
navigating, server support and execution have been developed. GLIF3 is an evolving 
version of GLIF, intended to address implementation more completely (see 
www.glif.org).   
 
Guidelines are modeled in GLIF at three levels of abstraction. First, medical experts 
define a conceptual flowchart of clinical actions, decision, and patient states. Then, 
informaticians specify a computable specification that can be verified for logical 
consistency and completeness. Third, an implementable specification is created that 
can be incorporated into particular institutional information systems. 
 
The GLIF3 model is object-oriented. It consists of classes, their attributes, and the 
relationships among the classes, which are necessary to model clinical guidelines. The 
model is described using Unified Modeling Language (UML) class diagrams. 
Additional constraints on represented concepts are being specified in the Object 
Constraint Language (OCL), a part of the UML standard. 
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3.3.1 Flowchart of GLIF  
 
• In GLIF, guidelines are represented as a flowchart of temporally sequenced 
nodes called guideline steps. Different classes of guideline steps are used for 
modeling different constructs. The flowchart, an instance of the Algorithm 
class in GLIF, contains instances from 5 classes of guideline steps: Decision 
(case and choice), action, branch, synchronization, and patient state [Peleg et 
al., 2000].  
 
 
• The first_step attribute indicates the starting point of the algorithm.  
 
• Next step, branches, and options attributes of the algorithm’s guideline steps 
provide the flow among the steps of the algorithm.  
 
A top-level view of the GLIF model is shown in Figure 1. 
 
 
Figure 3.3 The GLIF Model, a top-level view of main GLIF classes 
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3.3.2 Five categories of steps 
 
Now we will discuss in detail about the 5 categories of steps.  
  
• Decision_Step  
 
The Decision_Step class represents decision points in the guideline. A 
hierarchy of decision classes provides the ability to represent different decision 
models. 
 
Decision steps conditionally direct flow from one guideline step to another. 
GLIF provides a flexible decision model through a hierarchy of decision step 
classes. The Decision Step allows specification of both deterministic and non-
deterministic decisions.  
 
The decision hierarchy can be extended in the future to model decisions that 
consider uncertainty or patient preferences. The hierarchy may also be 
extended to support different decision models. 
 
Decision steps are nested by specifying a (sub) guideline in the decision_detail 
attribute of the step. This subguideline is executed before the decision criterion 
for that step is evaluated. The subguideline would modify or create new 
variable data items and assign them values. The use of these variables in the 
decision criteria makes the decision nested. Like the action step, a decision step 
has attributes that specify its strength of recommendation, strength of evidence, 
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didactics, iteration information, duration range, triggering events, and 
associated exceptions. 
 
Choice steps represent a decision between guideline steps for which the 
guideline does not provide deterministic selection criteria. An external agent, 
such as a human or another program, must make the decision in choice steps, 
and select one of the decision options.  
 
The case step provides a means to represent the conditional selection of exactly 
one path from among several alternatives. The “yes” and “no” options contain 
expressions of “True” and “False”, respectively, and direct the flow of control 




The Action_Step class is used for modeling actions to be performed. Action 
steps contain tasks. The action specification model includes two types of tasks:  
 
Guideline-flow-relevant actions, such as retrieving data from an electronic 
patient record, calling a sub-guideline, or computing values for data. They are 
Subguideline Action, Assignment Action, Generate Event Action, Get Data 
Object Action, and Get Data For Gel Action. 
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Clinically relevant actions, such as making recommendations. Clinically 
relevant actions reference the medical ontology for representations of clinical 
concepts such as prescriptions, laboratory test orders, or referrals. 
 
In GLIF, guideline encoders specify medical actions by defining the attributes 
of a Patient Data item according to the data model of the HL7 Reference 
Information Model (RIM). The HL7 RIM is general enough to represent the 
data structure for a wide range of medical data and concepts in a uniform 
manner, while using a small number of classes. Patient data can simply be 
modeled as observations, medications, and procedures. These classes contain a 
mood code that distinguishes how they can be conceived: as an event that 
occurred, a definition, intent, order, etc. 
 
The action step has attributes that specify its strength of recommendation, 
strength of evidence, didactics, iteration information, duration range, triggering 
events, and associated exceptions. Action Steps can be refined by including a 
task of Subguideline_Action type in the step. The Subguideline_Action task 
has a (sub) guideline attribute that contains the nested subguideline. An action 
step has a next step attribute that is used to specify the step to go to once this 




The Branch_Step and Synchronization_Step allow modeling of multiple 
simultaneous paths through the guideline. 
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The branch step is used to model concurrent guideline steps. Branch steps 
direct flow to multiple guideline steps. All of these guideline steps must occur 




Synchronization_steps are used in conjunction with branch steps. When 
multiple guideline steps follow a branch step, the flow of control can eventually 
converge in a single step. Each branch may lead to a series of steps, resulting in 
a set of branching paths. The step at which the paths converge is the 
synchronization step. When the flow of control reaches the synchronization 
step, a continuation attribute specifies whether all, some, or one of the 
preceding steps must have been completed before control can move to the next 
step. The continuation is expressed as a logical expression of guideline steps 
(e.g., (Step_A or Step_B) indicates that flow must continue once either Step A 




A Patient_State_Step is a guideline step (a node in the flowchart) that is used 
for two purposes. One purpose is to serve as a label that describes a patient 
state achieved by previous steps. In this way, a guideline may be viewed as a 
state transition graph, where states are scenarios, or patient states, and 
transitions between these states are the networks of guideline steps (excluding 
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patient state steps) that occur between two patient state steps. The other 
purpose of a patient state step is to serve as an entry point to the guideline (e.g., 




Nesting allows grouping of parts of a guideline into modular units (subguidelines or 
macros). This enables partitioning of the guideline parts into units of manageable size 
that can be comprehended more easily. These modular units can also be reused by 
other guidelines. 
 
Nesting is very useful for managing complex guidelines. Nesting enables looking at a 
guideline to be looked at from a top-level view, and then zooming into/out of some of 
its parts. Nesting is also useful in representing a guideline in the context of other 
guidelines. Since nesting allows grouping of parts of a guideline into a single unit, it is 
a mechanism that can allow model extensibility and reuse of parts of a guideline 
(defining macros), or adaptation of a guideline to a specific institution by replacing 
specifications for parts of a guideline (i.e., replacing a goal with a procedure). 
 
Decisions are nested by specifying a subguideline in the decision_detail attribute of a 
decision step. This subguideline is executed before the decision criterion for that step 
is evaluated. The subguideline would modify or create new variables and assign them 
values. The use of these variables in the decision criteria makes the decision nested. 
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Action Steps are nested by including a Subguideline_Action type of task in the step. 
The Subguideline_Action task has a subguideline attribute that contains the nested 
subguideline. 
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Chapter 4  
Methodology & System Architecture 
 
 
Based on the observations and analysis in Chapter 2 and Chapter 3, we present a new 
practical methodology to build decision models automatically from the knowledge-
based GLIF guideline models. We first identify the differences between the DMs and 
CPGs representations. Then related works are discussed. After that, we will describe in 
detail our methodology on the CPG-to-DM mapping, including the assumptions, the 
system architecture, the construction of the DM, and finally the model refinement.  
  
4.1 Comparison of DMs and CPG representations 
 
In recent articles, several authors analyze the differences between the DMs and CPGs 
[Zhu 2002, Sanders 1998, Hayward 1995, Kamae and Greenes 1991, Margolis 1983, 
US Congress Office of Technology Assessment 1994]. A DM specifies the probability 
that a specific clinical situation exists, and quantifies the value of the outcome of a 
decision. A CPG ideally has this information inherent in its recommendations, but does 
not represent the information explicitly for the guideline user. Table 4.1 summarizes 
the main differences between DMs and CPGs [Sanders 1998].   
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Table 4.1 Comparison of DMs and CPG representations 
 
Decision Models Clinical Practice Guidelines 
Specifies explicitly the probability that a 
particular clinical state exists 
Reflects only implicitly the underlying 
utilities and probabilities 
Quantifies the value of the outcome of a 
decision 
May rely on qualitative reasoning 
Answers: (1) Is it more desirable to do A 
or do B? (2) With what probability is A 
the most desirable action? 
Algorithm prescribes that, given X, do Y 
Focuses on pivotal decisions at a local 
stage 




4.2 Related work 
 
Although researchers have promoted CPG based clinical decision support, they have 
not done a large amount of work on transforming between DMs and CPGs. Two 
relatively early studies are work by Shiffman and his colleagues on the use of decision 
tables to improve clinical guidelines [Shiffman et al., 1992], and work by Kamae and 
Greenes on the use of a computational model of approximate Bayesian inference for 
associating clinical algorithms with decision analyses [Kamae and Greenes 1991]. 
 
More recently, Sanders [1998], in her PhD work, developed a new approach that 
allows developers and users to create, disseminate, and tailor CPGs, using normative 
decision models (represented as decision trees). She proposed that guideline 
developers use computer-based DMs that reflect known global and site-specific data to 
generate evidence-based CPGs. In her approach, she defined conceptual models for 
representing CPGs and DMs, and formalized a system (ALCHEMIST) for mapping 
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between these two representations. Such CPGs could then be tailored to specific 
clinical settings, and could also be modified automatically over time as the underlying 
DM or evidence evolves.  
 
However, her source decision model is only applied to decision trees, and her approach 
ignores vocabulary issues. The system does not place any restrictions on the naming 
conventions that the decision analyst uses when he builds the underlying DM. It would 





















Figure 4.1 Schematic representation of ALCHEMIST’s architecture [Sanders 
1998] 
 
Another work is by Zhu in her master thesis in 2002. They present a new practical 
methodology to facilitate effective dynamic decision model construction for evidence-
based clinical practice guideline development, updating and customization. The central 
idea of their methodology is the extraction of the information in existing paper-based 
CPGs to instantiate a predefined CPG conceptual model (Their CPG conceptual model 
is based on Sanders’ work, 1998). Then the information captured in the CPG 
conceptual model combined with additional information from other information 
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sources will be mapped to the Dynamic Decision Model (DDM) conceptual model and 
instantiated by it. Finally, based on the information of the DDM conceptual model, a 
DDM is constructed manually and solved to support automated generation of a new 
computer-based CPG, which may be customized and updated easily and efficiently. 
The DDM construction is an iterative process, which also requires multiple rounds of 



















Figure 4.2 Methodology of Zhu’s Work [2002] 
 
There are also some guideline-based clinical decision support systems that use the 
knowledge based structure, like the EON decision support system in Stanford 
University [Samson et al., 2001], the PRODIGY system in the United Kingdom 
[Johnson et al, 2000], the ATHENA project in the Veteran’s Affairs Palo Alto Clinic 
[Goldstein et al, 2000]. In their decision models, they implement if-then-else 
constructs and a form of argumentation – rule-in and rule-out criteria as a way of 
setting qualitative preferences – for decision making with a non-deterministic choice. 
   
GUIDE [Quaglini et al., 2001] is part of a guideline modeling and execution 
framework being developed at the University of Pavia. It supports (1) integrating 
modeled guidelines into organizational workflows, (2) using decision analytical 
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models such as decision trees and influence diagrams, and (3) simulating guideline 
implementation in terms of Petri nets (formal model used to model concurrent 
systems). 
 
GUIDE has a model that uses decision trees or influence diagrams to represent non-
deterministic choices. GUIDE provides a link to Java applets that build and use 
decision trees or influence diagrams that are specific to a situation addressed in a 
guideline. When a guideline user makes a decision, within a non-deterministic one-of 
choice, she may select one of the choices or ask for help. When help is requested, a 
decision tree or influence diagram, the location of which is specified by a URL, can be 
invoked. Once a decision tree is requested, it must be instantiated with probabilities 
and utilities. This process is partially automatic (for information that may be stored 
into a static database table, such as test characteristics, namely sensitivity, specificity 
and cost). Other data are provided by the EMR or the user through utility assessment 
tools. These models can be used, for example, to calculate incremental cost-
effectiveness or cost-utility ratios. Different considerations such as cost or life 
expectancy may influence the utility of a choice alternative. The final recommended 
alternative is calculated based on the expected utility for each possible alternative. 
 
Other relevant representation formalisms include those that incorporate an uncertainty 
model to a hierarchical representation framework.  Some of these efforts attempt to 
accommodate the uncertainty models by re-interpreting the semantics of existing 
representations [Lin et al., 1990, Yen et al., 1990],  while others try to couple the two 
to form a coherent framework [Saffiotti 1990]. However, none of these frameworks 
integrates context-sensitive categorical and uncertainty knowledge in a general way. 
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4.3 CPG – to – DM Mapping 
4.3.1 Assumptions 
 
Before we introduce our new methodology for the DM construction from knowledge-
based guideline models, we state some assumptions about the system. First, we assume 
that there exists one GLIF-based CPG model of high quality judged by the criteria 
specified by the Institute of Medicine (IOM): validity, reliability, applicability, 
flexibility, clarity, multidisciplinary process, scheduled review, and documentation 
[IOM, 1992]. The target problems and target population of the CPG selected are the 
same as those of the DDM that we intend to construct [Zhu 2002]. 
 
Second, in order to simplify the system, we assume that the clinical decision problem 
could be formulated in a non-dynamic decision model. Although many clinical 
decision problems are dynamic and take into account the effect of time, we could still 





Figure 4.3 Information known before decision is made 
 
Figure 4.3 shows that the outcome of event A is known before carrying out decision D, 
while from Figure 4.4, we know that decision T is made before decision D. 
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 D T 
 
 
Figure 4.4 Decision T is made before decision D 
 
As such, it is reasonable to assume that non-dynamic influence diagrams could also 
represent the sequence of the decision problem.  
 



















Figure 4.5 Proposed system architecture 
 
Figure 4.5 shows an overview of the proposed system architecture for ACDMC 
(Automated Clinical Decision Model Construction), which is designed to build the 
rough decision model automatically from the knowledge-based CPG model, and then 
to refine the decision model by the decision maker with additional information. 
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4.3.2.1 The knowledge base 
 
Since an ontology typically does not contain instances of concepts, we can view a 
knowledge base as an instantiation (or an extension) of an ontology. Thus, a 
knowledge base comprises “filled in” concept descriptions that enumerate the details 
of the particular application being built. In the ACDMC system for guideline-based 
medical care, a general ontology defines the general structure of clinical guidelines 
(the notions of drug therapy, laboratory tests, etc.); the particular knowledge bases on 
which ACDMC operates define specification for particular guidelines (i.e., individual 
guidelines for chronic cough, hypertension, thyroid, etc.). 
 
Given domain ontology, knowledge acquisition systems such as Protégé allow 
straightforward entry of the corresponding knowledge base. The protégé system 
permits developers to create a domain ontology using a simple editing system. Protégé 
then uses the domain ontology to create a user interface through which subject-matter 
experts can enter the detailed content knowledge base. The tools generated by Protégé 
can also be used to browse and to update the knowledge base as necessary – provided 
that the overarching domain ontology remains constant. 
 
A guideline modeler uses the Protégé-2000 knowledge-editing environment to create 
and maintain clinical practice guidelines (CPGs) and protocols. As we introduced in 
the previous chapter, Protégé-2000 has a frame-based knowledge model: all entities in 
a Protégé knowledge base – instances, classes, slots, faces, and constraints – are frames. 
Instances represent objects in the domain of interest (e.g. a patient). Classes are either 
named collections of instances or abstract conceptual entities in the domain (e.g. the 
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concept of a drug ingredient).  Slots are binary relations describing properties of 
classes (e.g. the indications of a drug). Faces describe properties of slots (e.g. the data 
type of a slot’s value).  
 
The medical ontology also provides a data model (e.g., Health Level 7’s Reference 
Information Model version 1.0) and a controlled vocabulary (e.g., UMLS) for 
referencing patient conditions and therapies that are relevant to managing disease. 
Together with the guideline model, it builds up the knowledge base for clinical 
decision making.  
 
4.3.2.2 Overview of the Decision Model Construction 
 
Many guideline-based decision models use rule-based criteria as a way of setting 
qualitative preferences. For example, in hypertension control, if blood pressure is 
inadequately controlled for less than six months, the guideline leaves the decision to 
the clinician’s judgment. In our method, we envision incorporating expected values 
computed from a decision-theoretic model to the hierarchical representation 
framework. 
 
Given a task to automate, the challenge is to construct an appropriate problem-solving 
method, and to link that problem solver to an ontology that defines the relevant 
concepts in the application area. Thus in our work, we develop an algorithm to 
automatically build a rough decision model (RDM) from the knowledge base described 
above. The rough decision model (RDM) is a decision model that is not complete in 
the structure, or parameters, or both. It is essential to emphasize that this generation 
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effort should occur within a progressive DM formulation framework. The purpose of 
such a framework is not to produce an approximately “correct” model but rather to 
help the decision-maker and his or her teams of experts develop insight about their 
decision. It is at the formulation phases of the Decision Analysis Cycle (sec. 1.1.2). 
With the rough model, the decision maker could construct the complete decision model 
by modifying the rough decision model and filling in additional information like 
probabilities and utilities.  
 
Our current effort concentrates on analyzing and representing the structure and 
contents of the clinical decision model. Issues related to other parts of the system, like 
evaluation of the decision model, will be mentioned without further analysis. Moreover, 
in this work, the only decision models that we focused on are the influence diagrams 
(IDs). IDs not only provide an explicit representation of probabilistic dependence and 
independence (compared to decision trees and qualitative probabilistic networks 
(QPNs)), but also represent the decision variables and preference values (compared to 
Bayesian networks (BNs)). These characteristics are essential in clinical decision 
making.  
 
4.3.3 Construction of the Decision Model 
 
The representation of a decision problem can be seen at three levels of specification: 
relation, function, and number [Howard and Matheson, 1981]. The relation level 
captures the qualitative structure of the problem, as expressed in the topology of the 
influence diagram. At this level, the arcs specify dependence and independence 
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between propositions or variables (nodes). IDs at the relation level are similar to 
several common representations in modeling and AI research, such as semantic nets.  
 
The level of function specifies the qualitative functional form of the probabilistic and 
deterministic relationships among nodes. 
 
The level of number quantifies the numeric values in the functions and conditional 
distributions. For example, at the level of number, we might specify that P(chest pain 
=mild discomfort | coronary artery disease = 1 vessel) = 0.25.  
 
According to these three levels, our system will automatically generate a rough 
decision model on the first relation level. In the model refinement stage, with the 
additional information from the decision maker, the system could complete these three 
levels.    
 
4.3.3.1 Decision model assumptions 
 
The decision model assumptions [Zhu 2002] include the basic characteristics of the 
decision problem, and some constraints on the actions, events, and states. In GLIF, the 
goals/intentions of the CPG are described in text strings in the “Intention” slot of the 
guideline model [Peleg et al. 1998]. So we map the “Intention” slot to the objective of 
decision model. The information inherent in the goals/intentions of CPG model can 
help DM developers to decide on the basic characteristics of clinical decision problems 
(e.g., the problem type, target population).  
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Furthermore, the overall eligibility criteria of the guideline model usually specify the 
target population of the disease problem. For example in hypertension, add a second 
drug guideline (the Sixth Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure) that states the value of 
the instance of the “eligibility criteria” class is “the patient is not at the goal blood 
pressure, the response to the initial drug choice for hypertension is inadequate after 
reaching the full dose, and the patient is tolerating the first choice well”. We can see 
that the target population is clearly identified for this guideline.  
 
Another example in the chronic cough management guideline is that, the objective of 
the CPG model includes the following information: diagnosis and treatment of chronic 
cough in immunocompetent adults (people of age >18 years). Chronic cough is defined 
as cough that lasts 3 weeks or more. Some etiological evidence indicates that chronic 
cough is due to three coincident diseases 42% of the time [Irwin et al., 1998]. 
Furthermore, the most common causes of chronic cough are: Postnasal Drip Syndrome 
(PNDS) (10% to 58%), Asthma (22% to 59%), Gastro esophageal Reflux Disease 
(GERD) (6% to 21%). 
 
Based on such information, in the DM construction, the problem type may be defined 
as diagnosis and treatment of chronic cough. The target population is people of age 
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4.3.3.2 Mapping Model Structure 
 
With the fundamental problem type, goals, target population specified, and sorted out 
from the general information of the guideline, we can turn now to the process of 
structuring the various decision elements – decisions and alternatives, uncertain events 
and outcomes, and consequences. The system obtains a large portion of the needed 
information directly from the clinical guideline model. We use the clinical algorithm 
to build the structure of the decision model and map the parameters and ontological 
contents from the medical ontology. Recall that the steps of the algorithm are 
subclasses of the Guideline_Step class. Each subclass is used for a step with a different 
purpose. Each step has a name and associated didactics. 
 
After we load the Clinical Practice Guideline model in GLIF, and medical ontologies, 
which are information models, the system first initializes an empty influence diagram 
network. After initializing the ID, the system adds to it the first_step of the flowchart 
algorithm, and label the first_step as the CurrentStep. As discussed in the previous 
chapter, the first_step is a Patient_State_Step. In ACDMC’s ID representation, this 
step corresponds to creating a chance node that is related to the patient state. The 
system creates the ID representation by determining the step type of CurrentStep and 
performs the actions in detail from a) to d) as follows, until there are no more steps in 
the flowchart algorithm for the system to traverse.  Figure 4.7 gives the algorithm for 
the structure mapping.  
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 Input:    Medical domain knowledge 
              CPG model in GLIF developed in Protégé-2000 environment 
Output:  Rough Decision Model   
 
Procedure: 
1. Load medical knowledge base (KB) and GLIF clinical guideline model  
2. Build the model structure with the CPG flowchart algorithm 
2.1 Begin with first_step, connect the nodes with the next_step, Branch_Step, 
decision options attribute 
2.2 node name Æ name of the step instance 
2.3 node type:  
      chance node Æ Patient_State_Step (disease info, risk factor, patient info) 
      decision node Æ action_step, decision_step (choice / case step)  
           decision alternatives: decision options attribute 
      utility node Æ leave a default value, let the decision maker fill in 
2.4 delete Synchronization_Step, Branch_Step (do not consider time issue), 
connect the parent and child nodes 
2.5 extract information from the KB to instantiate the nodes, evidence and support 
for decision making.  
2.6 Traverse the overall flowchart until the end node. 
3. Output target rough decision model. 
 
 





a) Patient State Step  
 
The patient state includes all the manifestations, i.e., signs, symptoms, laboratory 
findings, and complications that are applicable in the example cases [Leong 1990]. 
Some examples are fever, cough, and bronchospasm. We also classify concepts for 
describing the general background such as age, sex, drug-abuse-history, and 
hemophiliac as patient state. These information have close correspondence with the 
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Chance Node in the decision model, such as disease & background, signs & 
symptoms, test results, treatment results, treatment complication, follow-up results, 
and follow-up complication. So if the CurrentStep is a Patient_State_Step, we 
would map it as a chance node.  
 
Taking the cough study as an example, the algorithm maps the attributes of the 
GLIF Guideline Model to the DM as the following:   
 
Table 4.2 Attributes mapping from GLIF guideline model to DM 
 
Attributes GLIF Guideline Model DM 
Name Chronic Cough Chronic Cough 
ID CoughStudy_00005 CoughStudy_00005 
type Patient_State_Step Chance Node 
next_step Instance (CoughStudy_00010 
of Cls(Action_step)) --  Get 
Patient Cough-related data 
connecting information of the 
network (arc between node 
“chronic Cough” and “Get 
Patient Cough-related data”) 
patient_state_ 
description 
Instance of Cls (Three_ 
valued_Criterion): Current 
cough start time, Age, 
ImmunocompromisedEndTime
general background of patient 
Probability  not applicable assessed by the decision maker 
or set a default value, such as 0.5 
 
 
First, we map the value of the name, identity_code attribute from the 
Patient_State_Step to the Chance node in the decision node, respectively. As we 
have introduced in the GLIF guideline model in section 3.3.2, next step, branches, 
and options attributes of the algorithm’s guideline steps provide the flow among 
the steps of the algorithm. We use the value of the next step attribute to connect the 
nodes “chronic cough” and “get patient cough-related data”. The 
patient_state_description attribute describes the three valued criterion of the state 
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of the patient: current cough start time, age, and ImmunocompromisedEndTime. 
These attributes could be further modeled as chance nodes that are connected to the 
chronic cough node. 
 
b)  Action_Step 
 
As we introduced in section 3.3.2.2, the Action_Step has two types of tasks 
attributes: guideline-flow-relevant actions and medically oriented action. These 
two types of task specify the details of a clinical action and we could model them 
as decision nodes. If the tasks belong to the guideline-flow-relevant action classes, 
such as Assignment_Action_Class, Generate_Event_Action_Class, Get_Data_ 
Action_Class, we shall model the tasks separately as decision nodes. For example, 
the Action_Step - Get Patient Cough-related data - in the chronic cough 
management guideline, contains tasks like get Immunocompromised, get date of 
birth, get smoking, get PNDS, get pregnancy, get cough, and get ACEI. These 
tasks involve data related to the patient states, which could be represented as an 
encapsulated network of disease & background.  
 
If the tasks belong to the medically relevant action classes, such as making 
recommendations, we can directly map it to the decision node. 
 
c)  Decision_Step 
 
The decision step includes Choice_Step and Case_Step. It conditionally directs 
flow from one guideline step to another. So it does not have a “next_step” attribute, 
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but it has the decision_options attribute. Note that the decision options are not 
guideline steps. When using Protégé as an authoring tool for GLIF3, decision 
options are not graphically depicted as flowchart nodes. Instead, they are depicted 
as connectors.  
 
The value of Decision_options attribute is related to the alternatives of the decision 
node. The decision options’ criteria in a case should be mutually exclusive. If these 
criteria are not mutually exclusive, and more than one decision option criteria are 
met, then only one decision option is chosen, arbitrarily. 
 
d)  Branch_Step and Synchronization_Step 
 
Since this work does not concentrate on time issues, the Branch_Step and 
Synchronization_Step, which are used to model multiple simultaneous paths 
through the guideline, are used only in mapping the qualitative dependence of the 
variable nodes.  
 
 
4.3.4 DM Refinement 
4.3.4.1 Rationality of the DM 
 
From the rough decision model, the decision maker shall first check the structure of the 
influence diagram: 1) Whether it represents the decision problem rationally, explicitly, 
and completely, in both the nodes and their relationships. 2) Representation 
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requirement of the ID, like the node that no cycles are allowed in the IDs, no-
forgetting-arcs, etc.  
 
4.3.4.2 Numerical Parameters 
 
After building the model at a structural (relation) level, the system should assess the 
numerical parameters, including value functions, conditional probability distributions 




As part of modeling a decision problem, the analyst must decide which attributes of the 
possible outcomes to include in the analysis. In general, a medical decision results in 
outcomes that affect the attributes of length of life, quality of life, and monetary costs; 
the utility function to be used in the analysis is an assertion by the analyst of the 




For some events, there can be relevant empirical data to guide probability assessment. 
But for many real problems, most or all probabilities will need to be obtained from 
expert judgment [Henrion et al., 1991]. In addition, the decision maker shall take the 
preferences of the patient into the value function. 
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4.3.4.3 Level of representation 
 
 
Since the domain information in the Protégé-2000 knowledge base is organized in a 
hierarchy of classes, we are able to create IDs at different levels. The level of detail for 
the decision model is controlled by the user and should take into account the 
computational cost and the information gathering cost.  
 
In addition, in our decision model, we also support nesting of the decision or chance 
nodes. Nesting enables a decision model to be looked at from a top-level view and then 
zooming into/out of some of its parts. Nesting is also useful in representing a sub 
decision model in the context of the overall decision hierarchy.    
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Table 4.3 Mapping from GLIF guideline model to DM 
 
GLIF guideline model Medical ontology 
support 
Decision model 
Problem type Goals/intentions 




Eligibility Criteria of 
the overall guideline 





patient state step 
(structure) 










attributes of a 
Patient Data item 
according to the 








possible outcomes -- 
patient state step 
(structure) 











concept relations Contextual 
dependencies from 
the guideline model. 
Probability assessed 
by decision maker.  
arcs and 
probabilities 
evaluation criteria  cost, morbidity, 
mortality, quality-
adjusted life 
expectance (QALE),  
 
utility 
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To evaluate the proposed methodology to construct a DM from an existing knowledge-
based GLIF guideline model, we have conducted a case study on chronic cough 
management. This chapter first introduces the background about the clinical problem 
addressed, and then presents the mapping process. 
 
5.1 Chronic Cough in Immunocompetent Adults  
 
5.1.1 Introduction to Chronic Cough 
 
Cough is consistently among the most common principal reasons for seeing a 
Physician [Bernstam 2000]. It is generally classified into acute (< 3 weeks) and 
chronic (lasting 3 weeks or more). Acute cough, though more common and may be 
accompanied by other serious illnesses, is usually self-limited and does not require 
evaluation or treatment. Chronic cough, on the other hand, has been shown to 
adversely affect the quality of life.  
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5.1.2 Problems in Chronic Cough Diagnosis and Treatment 
 
One of the difficulties with the diagnosis and treatment of chronic cough is that 
symptoms may be due to more than one cause in a given patient. In fact, statistical data 
shows that chronic cough is due to three coincident diseases 42% of the time [Irwin et 
al., 1998]. Furthermore, the common causes of chronic cough are very difficult to 
diagnose on the basis of history and physical examination. 
 
5.1.3 Notes on Chronic Cough Diagnosis and Treatment 
 
• Although there are many possible causes, the majority of chronic cough 
instances in immunocompetent adults is caused by post nasal drip syndrome 
(PNDS), asthma, Gastroesophageal reflux disease (GERD), or a combination of 
these. 
 
• Chest radiographs should be ordered before any treatment is prescribed in 
nearly all patients with chronic cough (Grade II-2). Chest radiographs do not 
have to be routinely obtained before beginning treatment for presumed PNDS 
in young nonsmokers and pregnant women, or before observing the result of 
discontinuation of an ACE Inhibitor (ACE-I) for 4 weeks for patients who 
developed cough shortly after they began to take an ACE-I. 
 
• When the chest X-ray result is normal, PNDS, Asthma, and GERD are the 
likely causes of chronic cough. In PNDS, sinusitis may be the cause for up to 
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approximately 30% of the time when the cough is nonproductive, and up to 
approximately 60% of the time when the cough is productive. 
 
A negative recommendation: Sinus CT scans are not routinely recommended 
for evaluating sinusitis as the cause of the cough. Four-view sinus radiographs 
should be ordered instead. 
 
• While 24 hour esophageal pH monitoring is the most diagnostically useful test 
for assessing GERD as the cause of the cough, conventional indices used by 
gastroenterologists for assessing esophagitis may be misleadingly normal. 
Therefore, until future studies provide better guidelines, the test should be read 
as normal when conventional indices are within the normal range and no 
suspicious reflux-induced coughs appear during the monitoring session (Grade 
II-2). 
 
5.2 Case description--Cough Guideline model in GLIF 
 
5.2.1 Purpose of the case study 
 
The main purpose of this case study is to develop a decision model which addresses 
diagnosis and treatment of chronic cough in people of age greater than 18 years, 
immunocompetent, and having cough for more than 3 weeks. The decision model is 
expected to find out the cause of the chronic cough and the corresponding treatment to 
cure the disease.     
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5.2.2 Knowledge base used in the case study 
 
For this case study, the knowledge bases that we use are: 
• Chronic Cough management guideline modeled in GLIF. The selected 
guideline was from ACP (American College of Physicians – American Society 
of Internal Medicine’s guideline for managing chronic cough), since it 
addresses the same clinical problem (chronic cough) that we intend to deal with.   
 
• Chronic Cough domain ontology provides a data model and a controlled 
vocabulary for referencing patient conditions and therapies that are relevant to 
managing chronic cough.  
 
5.2.3 File format of the knowledge-based guideline model 
 
5.2.3.1 Brief introduction on XML 
 
 
The GLIF guideline model and domain ontology contain the chronic cough guideline 
knowledge base. They are both modeled and maintained in the Protégé-2000 
environment. As we described previously, the guideline model in Protégé-2000 could 
be saved in XML format. XML stands for the eXtensible Markup Language 
(http://www.w3c.org/xml), a notation for marking up the content of documents. It is 
widely considered to be fundamental to the movement of content-rich documents 
across the internet, and to be a core technology for the Semantic Web, e-science and 
scientific Grids. The World Wide Web Consortium (W3C) recently adopted XML as a 
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standard and several major software vendors (including Microsoft, Sun Microsystems, 
Netscape, Adobe, and IBM) support XML. XML documents can be viewed in current 
web browsers and there are a rapidly increasing number of tools for handling XML 
documents. The major programming languages also have an application programming 
interface (API) for processing XML documents. 
 
Efforts are also underway to incorporate XML into widely used health care standards 
such as HL7. The Protégé team developed the XML Backend as the default storage 
format of Protégé files. Kahn et al. also explored the use of XML to mediate between 
components of the computer-based patient record (CPR) and sought to integrate 
existing web-based systems for structured reporting (SPIDER) and probabilistic 
decision support (BANTER) [Kahn et al, 1998].   
 
In addition, there exists some special tools for the XML file transformation, Xalan, 
which is an XSLT (a language for transforming xml files) processor for transforming 
XML documents into HTML, text, or other XML document types. It contains 
operators for selecting nodes from the tree, using templates to filter out the information, 
reordering the nodes, and outputting nodes.  
 
5.2.3.2 XML based Bayesian network format 
 
Over the last several years, there has been ongoing discussion of the potential value of 
creating a Bayesian Network Interchange Format (BNIF) to enhance the exchange of 
knowledge and experimental results in the community in the Uncertainty and Artificial 
Intelligence (UAI) community (http://www.uai.org). During the 1998 Conference on 
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UAI in Madison, Wisconsin, there was a panel discussion about the future of the BNIF. 
The discussion converged on the value of leveraging XML to revitalize the BNIF 
efforts. Later, several research groups proposed formats on the XML-based BN, 
including XMLBIF (XML-based BayesNets Interchange Format), developed by  
Fabio Cozman et al (http://www-2.cs.cmu.edu/~fgcozman/Research/ Interchange 
Format/), and XBN (for "Bayesian network in XML"), developed by the DTAS group 
at Microsoft Research (http://www.research.microsoft.com/ dtas/bnformat/).  
 
The XMLBIF format is being implemented in the JavaBayes (http://www-
2.cs.cmu.edu/~javabayes/), GeNie systems and BNJ (http://bndev.sourceforge.net/ 
history.html); there have been signs that implementations in the Netica and Hugin 
systems are in the works.  
 
As such, we use the cough guideline model saved in XML format as the input of our 
system. It includes the following files: core_GLIF, Cough Study, Data_Model 
(RIM_USAM), Diagram, GLIF 3.4, Global Concepts, User defined instance ontology. 
It is available online at (http://smi-web.stanford.edu/projects/intermed-web/guidelines/ 
GLIF1.htm) Figure 5.1 shows a screenshot of the knowledge model file.  
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Figure 5.1 Screenshot of the knowledge model in xml format 
 
 
In addition, we extend the XMLBIF to XML-based Influence Diagram (XMLID), as 
the format of our output decision model. The details of XMLBIF, including the 
description of the format, DTD file (Document Type Description), and examples could 
be found at the website: http://www-2.cs.cmu.edu/~fgcozman/Research/Interchange 
Format/. The DTD file for the XMLID format is shown in Figure 5.2.  
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 <!-- DTD for the XMLID format --> 
<!DOCTYPE XMLID [ 
 <!ELEMENT XID (NETWORK)*> 
  <!ATTLIST XID VERSION CDATA #REQUIRED> 
 <!ELEMENT NETWORK (NAME, (PROPERTY | VARIABLE | 
PROBABILITY)*)> 
 <!ELEMENT NAME (#PCDATA)> 
 <!ELEMENT PROPERTY (#PCDATA)> 
 <!ELEMENT TYPE (#PCDATA)> 
 <!ELEMENT VALUE (#PCDATA)> 
 <!ELEMENT VARIABLE (NAME, (VALUE | PROPERTY)*)> 
  <!ATTLIST VARIABLE TYPE (chance | decision | utility) "chance"> 
 
<!-- topological dependency structure information --> 
 <!ELEMENT STRUCTURE (ARC|MEMBER)*> 
 <!-- specify dependency arc --> 
    <!ELEMENT ARC EMPTY> 
         <!ATTLIST ARC  
         PARENT NMTOKEN #REQUIRED 
         CHILD NMTOKEN #REQUIRED> 
 <!-- specify set inclusion for parentless variables --> 
   <!ELEMENT MEMBER EMPTY> 
         <!ATTLIST MEMBER NAME NMTOKEN #REQUIRED> 
 
<!-- specify probability --> 
 <!ELEMENT PROBABILITY (FOR | GIVEN | TABLE | ENTRY | 
DEFAULT | PROPERTY)*> 
 <!ELEMENT FOR (#PCDATA)> 
 <!ELEMENT GIVEN (#PCDATA)> 
 <!ELEMENT TABLE (#PCDATA)> 
 <!ELEMENT DEFAULT (TABLE)>  
      <!ELEMENT ENTRY (VALUE*, TABLE)> 
 
Figure 5.2 DTD file for XMLID 
 
 
The system described here could also be extended to incorporate client-side Java 
software for data entry and inference. XML has the potential to facilitate the 
integration of data entry, decision support, and other components of the evolving 
computer based patient records.   
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5.2.4 Chronic Cough Management DM Formulation 
 
To begin with our ACDMC system’s DM construction process for chronic cough, we 
first map the information of the GLIF guideline model to the decision model 
assumptions. Since in the GLIF, goals and intentions are described as text strings in the 
“Intention” slot of the guideline, we could have: 
 
Problem type: diagnosis and treatment of chronic cough.  
 
Target population: people of age >18 years, immunocompetent, and have cough for 
more than 3 weeks. 
 
Evaluation Criteria: Cost/effectiveness, quality-adjusted life expectance (QALE). 
   
Next, we proceed to the mapping of the decision model structure. We use the influence 
diagram representation of the DM. Recall that an influence diagram is a directed, 
acyclic network of 4 kinds of nodes, i.e., decision node, chance node, deterministic 
node, and value node. We use the step class, subclass of the clinical algorithm class, to 
form the top level structure of the influence diagram. Figure 5.3 shows the flow chart 
of the top level cough management algorithm, and the Treatment of cough is modeled 
as a subguideline as represented in Figure 5.4. The starting-point of the diagram is 
mapped from the first_step of the algorithm, which is a Patient_State_Step. The details 
of the mapping from Patient_State_Step (Chronic cough) to Chance node (chronic 
cough) are shown in Table 5.1. The   
 


















































Figure 5.3 The top-level cough management algorithm. 
• Description of Figure 5.3 
First, relevant patient data is collected in an action step. Then we decided whether 
“suspecting ACEI as the cause of cough” (a choice step). If ACEI is suspected to 
be the cause of cough, then we order to stop the ACEI through the action step 
“Order stop ACEI for 4 weeks” that has a medically-oriented action specification 
task. At the time that the order to stop ACEI is given, the current time is assigned 
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to the variable “time_ACEI_stopped”. This will be used to determine the time of 4 
weeks after ordering to stop ACEI, in the patient state step -- "4 weeks passed?".  
 
The patient is sent home for 4 weeks. If 4 weeks passed, then the patient is 
evaluated through the action step “Evaluate patient”. This action has a Get_Data 
task that queries for the status of the latest Cough. This action step follows a 
patient state step that marks a state of at least 4 weeks after the patient was taken 
off ACEI. Instead of using a patient state step, the action step of ”Evaluate patient” 
can be triggered by an event that signals that 4 weeks passed, as shown in the 
action step’s triggering_events slot. Having a triggering event means that we 
monitor for the event and when it occurs, we trigger the action step. It is different 
from having the patient come in for a visit and then matching his state to the entry 
points of the guideline (the patient state steps). 
 
After the patient is evaluated, and the latest Cough value is taken, we can ask if the 
cough is gone. This is done via a choice step that has two options: “yes” and “no”. 
The Rule-in for the “yes” option is shown below. Now that we have observed the 
patient for 4 weeks we can go on to the rest of the guideline. The next step is a user 
choice step. The user needs to decide whether there are reasons to withhold the X-
Ray or not. If we need to withhold the X-Ray, we perform the X-Ray and the 
Treatment sub-guideline in any order and then wait until the “Treatment” action is 





























Figure 5.4 The treatment of cough algorithm. 
 
• Description of Figure 5.4 
The “Initialization” action step is used to initiate the values of flags that specify 
whether PNDS was evaluated, GERD was evaluated, and Asthma was evaluated. 
The treatment sub-guideline lets the user execute the 3 evaluation actions in any 
order. Synchronization occurs after the cough is resolved, or after all three 
evaluation action steps were executed. The user should decide whether the test 
results are normal. When an evaluation step is executed, the appropriate flag is set 
to “True”. The automatic case step “more evaluation necessary” checks to see 
whether one of the evaluation flags signals that an evaluation was not done yet. Its 
result matches “True” or “False” and this determines the traversal of the algorithm. 
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Table 5.1 The mapping of Patient_State_Step to Chance Node 
 
Attributes GLIF Guideline Model DM 





type Patient_State_Step Chance Node 
next_step Instance (CoughStudy_00010 
of Cls(Action_step)) --  Get 
Patient Cough-related data  
connecting information of the 
network (arc between node 
“chronic Cough” and “Get 
Patient Cough-related data”) 
patient_state_ 
description 
Instance of Cls (Three_ 
valued_Criterion): Current 
cough start time, Age, 
ImmunocompromisedEndTime
general background of patient 
Probability  not applicable assessed by the decision maker 
or set a default value, such as 0.5 
 
 
Since the Next_step, branches, and options attributes of the algorithm’s guideline steps 
provide the flow among the steps of the algorithm, we catch the information of these 
attributes of the steps to generate the arcs of the influence diagram.  
 
Then we perform the actions detailed in 4.3.3.2, for the mapping of the action_step and 
the decision_step (choice_step / case_step) to a decision node, until there are no more 
steps in the clinical algorithm for the system to traverse.  Tables 5.2 -5.3 are some 
examples of the mapping. Figure 5.5 shows the nested representation of the decision 
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Table 5.2 The mapping of Action_Step to Decision Node 
 
Attributes GLIF Guideline Model DM 
Name Get Patient Cough-related data Get Patient Cough-related data 
ID CoughStudy_00010 CoughStudy_00010 
type Action_Step Decision Node  
next_step Instance (CoughStudy_00107 of 
Cls(Choice_step)) --  Suspecting 
ACEI as cause of cough? 
Connecting information of the 
network (arc between node “Get 
Patient Cough-related data” and 
“Suspecting ACEI as cause of 
cough?”) 
Get Immunocompromised 







The content of the tasks relate to 
the patient background, signs 
and symptoms of the disease, so 
it could be represented as a 
nested network in the decision 



















Figure 5.5 The nested representation of the decision node 
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Table 5.3 The mapping of Decision_Step (choice/case step) to Decision Node 
 
Attributes GLIF Guideline Model DM 
Name Suspecting ACEI as cause of 
cough? 
Suspecting ACEI as cause of cough? 
ID CoughStudy_00107 CoughStudy_00107 
type Choice_step Decision Node 
options CoughStudy_00122 of Cls 
(Decision_Option) – No 
CoughStudy_00122 of Cls 
(Decision_Option) – Yes 
Decision alternative: “Yes” or “No”. 
 destination attribute of “Yes” 
and “No” 
connecting information of the 
network (arc between node “chronic 




After parsing the whole cough management algorithm, we could get a rough decision 
model as shown in Figure 5.6. It may not be a complete model and may even not be a 
valid ID, but it represents the overall structure of the decision problem. Our case study 
of chronic cough is comparatively simple, but many other decision problems in the 
medical domain are rather complex and involve a huge amount of nodes and arcs. So 
the top level ID could give a neat view of the structure and the decision maker may 
refine the model with different levels of representation.  In addition, we illustrate the 
rough decision model in XMLID in Appendix A.   
 





ACEI for  
4 weeks 
Utility 

















Figure 5.6 The rough decision model 
 
 
The knowledge base usually contains a lot of information. The domain knowledge are 
modeled in a hierarchical structure, and they are also linked with the concept 
relationship class in Protégé-2000 environment. If we want to get a more detailed DM, 
we could choose other levels of representation other than the top level. The lower 
levels are instantiated with more instance supports of the domain ontologies. 
Accordingly, the network is much bigger. Figure 5.7 illustrated the chronic Cough DM 
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Figure 5.7 Refined model 
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This work presents a new approach to support automated construction of clinical 
decision models from a knowledge base. The methodology aims to facilitate 
application of the decision analysis paradigm in clinical domains. We make use of the 
knowledge-based CPG model in GLIF format as the input knowledge model. Together 
with the medical ontologies, which provide structured data models and controlled 
vocabularies for referencing patient conditions and therapies that are relevant to 
managing disease, it builds up the knowledge base for clinical decision making.  
 
We develop an algorithm to automatically build a rough decision model (RDM) from 
the knowledge base described above. The RDM is a decision model that is not 
complete in the structure, or parameters, or both. However, it gives a neat view of the 
decision problem with the information extracted from the knowledge base. Rule-based 
references are widely used in many guideline-based decision models. We incorporate 
expected values computed from a decision-theoretic model to the hierarchical 
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representation framework. In addition, it greatly reduces the efforts needed for 
constructing a decision model manually. With the rough model, the decision maker 
could construct the complete decision model by modifying the RDM and filling in 




Our work facilitates the clinical model construction from the knowledge-based GLIF 
guideline system. It greatly reduces the huge amount of work needed for building the 
clinical DM.  
 
We also use the controlled vocabulary and structured data models, like HL7-RIM, to 
develop the decision model. It will ease the reuse and exchange of the DMs among 
different hospitals and institutes. 
 
In addition, the knowledge-based decision model will enable the support of 
information about CPGs and medical ontologies to be stated explicitly. The users will 
have a better understanding of reasons why specific options are better than others. It 
gives the users more flexibility in following local practices when existing 
recommendations support these practices.  
 
Another advantage of this model is the ease in representing changes for updating CPGs. 
When there are changes in disease prevalence or when new technology becomes 
available, it would be easier to update information in the model.  




Our current effort concentrates on analyzing and representing the structure and 
contents of the clinical decision model. In addition, we use the sequence of the nodes 
to represent the temporal precedence. However, many clinical decision problems are 
dynamic and need to encode time as a very important element. Thus, our system is not 
suitable for those problems. Dynamic decision models, like Markov decision process 
(MDP), need to be developed.   
 
 
6.4 Future Work 
 
The interesting topics in future work include the following: 
 
6.4.1 Evaluation of the decision model 
 
We save our target decision model in the XMLID (XML-based Influence Diagram) 
format. In the next step, we plan to transform the DTD file to XML Schema, which 
itself is in XML format. Then we will evaluate the ID model in JavaBayes 
(http://www-2.cs.cmu.edu/~javabayes/), GeNie (http://www2.sis.pitt.edu/~genie/), or 
other software supporting the XMLID format.  
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6.4.2 Extend the current decision model to a dynamic DM   
 
Certain clinical conditions require modeling of repetitive events or modeling of 
patients at continuous risk.  As discussed in the last section, a limitation of our system 
is that it cannot precisely represent the temporal sequence. So we plan to extend the 
current decision model to a dynamic decision model, like a Markov Decision Process. 
A Markov model (in the medical domain) is a type of state-transition model in which 
the transition probabilities depend on only the current patient state. It is one method in 
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Appendix A  
Rough Decision Model in XMLID Format 
 
<?xml version="1.0" encoding="UTF-8"?> 
 




  <NAME>Chronic_Cough</NAME> 
  <!-- Variables --> 
  <VARIABLE TYPE="chance"> 
   <NAME>Chronic_Cough</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>Present</VALUE> 
   <VALUE>Absent</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="decision"> 
   <NAME>Get_Patient_Cough_related_data</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>Get_Date_of_Birth</VALUE> 
   <VALUE>Get_Smoking</VALUE> 
   <VALUE>Get_Sex</VALUE> 
   <VALUE>Get_Cough</VALUE> 
   <VALUE>Get_PNDS</VALUE> 
   <VALUE>Get_ACEI</VALUE> 
   <VALUE>Get_Pregnancy</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="chance"> 
   <NAME>Pregnancy</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>True</VALUE> 
   <VALUE>False</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="decision"> 
   <NAME>Suspecting_ACEI_as_cause_of_cough</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>True</VALUE> 
   <VALUE>False</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="decision"> 
   <NAME>Order_Stop_ACEI_for_4_weeks</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE> Order_Stop_ACEI </VALUE> 
  </VARIABLE> 
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  <VARIABLE TYPE="decision"> 
   <NAME>Evaluate_patient</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>Evaluate_Cough</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="chance"> 
   <NAME>4_weeks_passed</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>True</VALUE> 
   <VALUE>False</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="decision"> 
   <NAME>Evaluate_Patient</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>Evaluate_Cough</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="chance"> 
   <NAME>Cough_Gone_1</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>True</VALUE> 
   <VALUE>False</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="decision"> 
   <NAME>Treatment_of_Cough</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>Evaluate PNDS</VALUE> 
   <VALUE>Evaluate Asthma</VALUE> 
   <VALUE>Evaluate GERD</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="decision"> 
   <NAME>XRay</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>chest_Xray</VALUE> 
  </VARIABLE> 
   
  <VARIABLE TYPE="utility"> 
   <NAME>Utility</NAME> 
   <TYPE>discrete</TYPE> 
   <VALUE>Utility table</VALUE> 
  </VARIABLE> 
   
 <!--Structure specify dependency arc--> 
 <STRUCTURE> 
         <ARC PARENT="Chronic_Cough" CHILD="Get_Patient_Cough_related_data"/> 
         <ARC PARENT="Get_Patient_Cough_related_data" 
CHILD="Suspecting_ACEI_as_cause_of_cough"/> 
         <ARC PARENT="Suspecting_ACEI_as_cause_of_cough" 
CHILD="Order_Stop_ACEI_for_4_weeks"/> 
         <ARC PARENT="Suspecting_ACEI_as_cause_of_cough" CHILD="XRay"/> 
         <ARC PARENT="Order_Stop_ACEI_for_4_weeks" CHILD="4_weeks_passed"/> 
         <ARC PARENT="4_weeks_passed" CHILD="Evaluate_patient"/> 
         <ARC PARENT="Evaluate_patient" CHILD="Cough_Gone"/> 
         <ARC PARENT="Cough_Gone" CHILD="XRay"/> 
         <ARC PARENT="XRay" CHILD="Treatment_of_Cough"/> 
         <ARC PARENT="Treatment_of_Cough" CHILD="Cough_Gone_1"/> 
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         <ARC PARENT="Cough_Gone" CHILD="Utility"/> 
         <ARC PARENT="Cough_Gone_1" CHILD="Utility"/> 
     </STRUCTURE> 
   
 <!-- Probability distributions --> 
  <PROBABILITY> 
   <FOR>Chronic_Cough</FOR> 
   <TABLE>0.5 0.5 </TABLE> 
  </PROBABILITY> 
     
…… 
 
 </NETWORK> 
</BIF> 
 
